Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05821075

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Comparative Study Between Prednisolone, Cerebrolysin in the Treatment of Bell's Palsy

Status
Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
October 6 University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy

Conditions

Interventions

TypeNameDescription
DRUGPrednisoloneprednisolone 60mg tablet once daily for 5 days then tapering dose
DRUGCerebrolysinintramuscular Cerebrolysin 10 mg daily for 3 weeks

Timeline

Start date
2023-08-24
Primary completion
2026-01-01
Completion
2026-02-01
First posted
2023-04-20
Last updated
2025-07-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05821075. Inclusion in this directory is not an endorsement.